GMAB

Genmab A/S

Healthcare›Biotechnology|NASDAQ Global Select|DK

Price

$27.50

Market Cap

$16.98B

Beta

0.74

P/E

6.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-35.24%

EPS Growth (YoY)-63.51%

Revenue CAGR 3Y-15.82%

P/E Ratio6.2

PEG Ratio—

FCF Yield+17.06%

Debt / Equity0.95

Interest Coverage29.1x

No credit card required

Already have an account? Sign in to view the full analysis for GMAB.